current user: public


Query: 2oev_A mol:protein length:705 Programmed cell death 6-interacting protein, from PDB0312

Results of FFAS03 search in PDB0312
Master-slave alignment does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .
# Score Template Links and tools%idFirst GIDPFTHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQYYFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARLast
1 -144.0002oev_A mol:protein length:705 Programmed cell death 6-interacting protein  ali model  100  1GIDPFTHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQYYFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFAR 705
2 -85.0002oew_A mol:protein length:380 Programmed cell death 6-interacting protein  ali model follow..  98  6.LYFQGHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMV................................................................................................................................................................................................................................................................................................................................................... 370
3 -73.9001zb1_A mol:protein length:392 BRO1 protein  ali model follow..  23  1GMGSMK--PYLFDLKLKDTEKLDWKKGLSSYLKKSYGSSQWRTFYDEKATSELDHLRNNANG--ELAPSSLSEQNLKYYSFLEHLYFRLGSKGSRLKMDFTWYDAEYSSA--QKGLKYTQHTLAFEKSCTLFNIAVIFTQIAR---ENINEDYKNSIANLTKAFSCFEYLSENFLNS----PSVDLQSENTRFLANICHAEAQELFVLKLLNDSKQYTLISKLSRATCNLFQKCHDFMKEAIYGEPKWKTTVTCKLHFYKSLSAYYHGLHLEEENRVGEAIAFLDFSMQQLISSLPFKTWLVDFDGFKETLEKKQKELIKDNDFIYHESVPAVVQVDSIKALDAIKSPTWEKILANKYDSLYRGIIPLDVYEKESIYSEEKATLLR............................................................................................................................................................................................................................................................................................................................... 392
4 -73.5003rau_A mol:protein length:363 Tyrosine-protein phosphatase non-receptor typ  ali model follow..  27  3.FEAVPRM-PMIWLDLKEAGDFHFQPAVKKFVLKNYG---ENPEAYNEELKKLELLRQNAVR--VPRDFEGCSVLRKYLGQLHYLQSRVPMGSGEAAVPVTWTEIFS-------GKSVAHEDIKYEQACILYNLGALHSMLGAMDKRVSEEGMKVSCTHFQCAAGAFAYLREHFPQA----YSVDMSRQILTLNVNLMLGQAQECLLEKSMLDNRKSFLVARISAQVVDYYKEACRALENPGRIQKDWKKLVQMKIYYFAAVAHLHMGKQAEEQQKFGERVAYFQSALDKLNEAIKLAKGQPDLRFTMDVIGGKYNSAKKDNDFIYHEAVPALDTLQPVKGAPLVKPLPVNPTDPATGPDIFAKLV................................................................................................................................................................................................................................................................................................................................................... 363
5 -68.1003zxp_A mol:protein length:407 BRO1 DOMAIN-CONTAINING PROTEIN BROX  ali model follow..  19  1GIDPFTMTHWFHRNPLKATAPVSFNYYGVVT--------GPSASKICNDLRSSRARLLELFTDLSCNPEMMKNAADSYFSLLQGFINSLDESTQESIQNFKWTDTLQ------GQVPSAQQDAVFELISMGFNVALWYTKYASRKENITEDEAKEVHRSLKIAAGIFKHLKESHLPKLITEKGRDLESRLIEAYVIQCQAEAQEVTIARAIELKHAPGLIAALAYETANFYQKADHTLSSEPAYSAKWRKYLHLKMCFYTAYAYCYHGETLLASDKCGEAIRSLQEAEKLYAKAEALCKEYGEFRKLGNLVKNTLEKCQRENGFIYFQKIPTEAPLELKANYGLVEPIPFEFPPTSVTPETLAAFDLTKRPKDDSTKPKPEEEVKPVKEPDIK........................................................................................................................................................................................................................................................................................................................ 407
6 -49.3002ojq_A mol:protein length:348 Programmed cell death 6-interacting protein  ali model follow..  99  6..............................................................................................................................................................................................................................................................................................................................................................................PVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVSVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFAR 344
7 -48.8002oex_A mol:protein length:351 Programmed cell death 6-interacting protein  ali model follow..  99  6...........................................................................................................................................................................................................................................................................................................................................................................THMPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFAR 347
8 -19.4001c1g_A mol:protein length:284 TROPOMYOSIN  ali model follow..  9  2.................................................................................................................................................................................................................................................................................................................................................................................................................................DAIKKKMQMLKLDKENLDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKYSEALKDAQEKELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIE----SRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEELDHALNDMTSI.... 284
9 -19.2002tma_A mol:protein length:284 TROPOMYOSIN  ali model follow..  11  1....................................................................................................................................................................................................................................................................................................................................................................................................MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEDRSKQLEDEL------VSLQKKLKGTEDELDKYSEALKDAQEKLELAEKKATDAEADV-------------ASLNRRIQLVEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDE----EKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAET------RAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEELDHALNDMTSI.... 284
10 -17.7001jch_A mol:protein length:551 COLICIN E3  ali model follow..  10  250.........................................................................................................................................................................................................................................................................................................................................................................................NNTDKDVRPAFGTQGGNTRDAVIRFPKDSGHNAVYVSVSDVLSPDQVKQRQDEENRRQQEWDATHPVEAAERNYERARAELNQANEDVARNQERQAKAVQVYNSR--KSELDAANKTLADAIAEIKQFNRFAHDPMAGGHRMWQMAGLKAQRAQTDVNNKQAAFDAAAKEKSDADAALMESRKKKEDKKRSAENNLNDEKNKPRKGFKDYGHDYHPAPKTENIKGLGDLKPGIPKTPKQNGGGKRKRWTGDKGRKIYEWDSQHGELEGYRASDGQLGSFDPKTGNQLKGPDPKRNIKKYL............................ 551
11 -16.3001qoy_A mol:protein length:318 HEMOLYSIN E  ali model follow..  11  33.................................................................................................................................................................................................................................................................................................................................................................................................................................ETADGALDLYNKYLDQVIPWQTFDETIKELSRFKQEYSQAASVLVGDIKTLLMDSQDKYFE-----ATQTVYEWCGVATQLLAAYILLFDEYNEKSAQKDILIKVLDDGITKLNEAQKSLLVSSQSFNNAS----GKLLALDSQLTNDFSEKSSYFQSQVDKIRKEAYAGAAAGVVVGPFGLIISYSIAAGVVEGKLIPELKNKLKSVQNFFTTLSNTVKQANKDIDAAKL------KLTTEIAAIGEIKTETETTRFYVDYDDLMLSLLKEAAKKMINTCNEYQK.. 305
12 -15.9001cii_A mol:protein length:602 COLICIN IA  ali model follow..  8  88...................................................................................................................................................................................................................................................................................................................................................................................EKDENTLKTLRAGNADAADITRQEFRLLQAELREYGFRTEIAGYDALRLHTESRMLFADADSRISPREARSLIEQAEKRQKDAQNADKKAADMLAEYERRKGILDTRLSEL--EKNGGAALAVLDAQQARLLGQQTRNDRAISEARNKLSSVTESLNTARNALTRAEQQLTQQKNTPDGKTIVSPEKFPGRSSTNDSIVVSGDPRFAGTIKITTSAVIDNRANLNYLLSHSGLDYKRNILNDRNPVVTEDVEGDKKIYNAEVAEWDKLRQRLLDARNKTSAESAVNSARNNLSARTNEQKHANDALNALLKEKENIRNQLSGINQKIAEEKRKQ 421
13 -14.7002v71_A mol:protein length:189 NUCLEAR DISTRIBUTION PROTEIN NUDE-LIKE 1  ali model follow..  9  2...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AMDFSSLKEETAYWKELSMKYKQSFQEARDELVEFQEGSRELEAELEAQLVQAEQRNRDLQADNQRLKYEVEALKEKLEHQYAQSYKQVSVLEDDLSQTRAIKEQLHKYVRELEQANDDLERAKRATIMSLEDFEQRLNQAIERNAFLEELDEKESLLVSVQRLKDEARDLRQELAVRERQQEVTRK....................... 189
14 -14.6001y1u_A mol:protein length:585 Signal transducer and activator of transcript  ali model follow..  8  1..............................................................................................................................................................................................................................................................................................................................................................................................................................SPAGVLVDAMSQKHLQINQR--FEELRLITQDTENELKKLQQTQEYFIIQYQESLRIQAQFAQLGQLN--PQERMSRETALQQKQVSLETWLQREAQ---TLQQYRVELAEKHQKTLQLLRKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEQNRQQIRRAEHLCQQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKLNVHMNPPQVKATIISEQQAKSLLKNENTRNECSGEILNNCCVMEYHQAT..... 282
15 -14.5003u0c_A mol:protein length:201 Invasin ipaB  ali model follow..  10  15.....................................................................................................................................................................................................................................................................................................................................................................................................................................................LTIADLTANQNINTTNAHSTSNILIPELKAPKSLNASSQLTLLI------GNLIQILGEKSLTALTNKITAWKSQQQARQQKNLEFSDKINTLLSETEGLTRDY-----------EKQINKLKNADSKIKDLENKINQIQTRLSELDPESPEKKKLSREEIQLTIKKDAAVKDRTLIEQKTLSIHSKLTDKSMQLEKEIDSFSA................................................................ 201
16 -14.3001yvl_A mol:protein length:683 Signal transducer and activator of transcript  ali model follow..  8  5..........................................................................................................................................................................................................................................................................................................................................................................................YELQQLDSKFLEQVHQLYDD-KQDWEHAANDVSFATIRFHDLLSQLDDQYSRFSLENNFLLQHNIRKSKRNLQDNFQEDPIQMSMIIYSCLKEERKILENAQRFNQAQSGNIQSTVMLDKQKELDSKVRNVKDKVMCIEHEIKSLEDLQDEYDFKCKTLQNREHETNGVAKSDQKQEQLLLKKMYLMLDN---KRKEVVHKIIELLNVTELTQNALINDELVEWKRRQQSACIGGPPNACLDQLQNWFTIVAESLQQVRQQLKKLEELEQ--KYTYEHDPITKNKQVLWDRTFSLFQQLIQ.......................... 314
17 -14.2003o0z_A mol:protein length:168 Rho-associated protein kinase 1  ali model follow..  11  5........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILE----NSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLT.................................................. 167
18 -14.1003ibp_A mol:protein length:302 Chromosome partition protein mukB  ali model follow..  9  1.........................................................................................................................................................................................................................................................................................................................................................................................GSHMIASLSDSVSNAREERMALRQEQEQLQSRI-----------QSLMQRAPVWLAQNSLNQLSEQCGEEFTSSQDVTEYLQQLLEREREAIVERDEVGAR------KNAVDEEIERLSQPGGSEDQRLNALAERFGGVLLSEIYDDVSLEDAPYFSALYGPSRHAIVVPDLSQVTEHLEGLTDCPEDLYLIEGDPQSFDDSVFSVDELEKAVVVKIADRQWRYSRFPEVPLFGRAARESRIESLHAEREVLSERFATLSFDVQKTQRLHQAFSRFIGSHLAVAFESDPEAEIRQLNSRRVELERALSNHENDNQQQR.......... 302
19 -14.1002efr_A mol:protein length:155 General control protein GCN4 and Tropomyosin  ali model follow..  10  1.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RMKQLEDKVEELLSKNYHLENEVARLKKLLERAEERAELSEGKS-----------AELEEELKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEEMKQLEDKVEELLSKNYHLENEVARLKKL.......................................... 155
20 -14.0003plt_A mol:protein length:234 Sphingolipid long chain base-responsive prote  ali model follow..  9  20.........................................................................................................................................................................................................................................................................................................................................................................................................................................................ELARKLSQLVKTEKGVLRAMEVVASERREAAKQLSLWGADNDDDVSDTDKLGVLIYELGELQDQFIDKYDQYRVTLKSIRNIEASVQPSRDRKEKITDEIAHLKYKDPQS-----TKIPVLEQELVRAEAESLVAEAQLSNITRE----------------KLKAAYSYMFDSLRELSEKFALIAGYGKALLELLDDSPVTPGEARPAYDGYEASRQIIMDAESALESWT.................................. 229
21 -14.0002nrj_A mol:protein length:346 Hbl B protein  ali model follow..  8  1.........................................................................................................................................................................................................................................................................................................................................................................................SLSEIEQTNNGDTALSANEARMKETLQKAGLFAKSMNAYSYMLIKNPDVNFEGITINGYVDLPGRIVQDQKNARAHAVTWDTKVKKQLLDTLNGIVEYDTTFDNYYETMVNTGDGETLKEGITDLRGEIQQNQKYAQQLIEELTKLRDSIGHDVRAFGSNKELLQSILKNQGADVDADQKRLEEVLGSVNYYKQLESDIVGVARDNLGKLEPLLAELRQTVDYKVTLNRVVGVAYSNINEMHKALDDAINALTYMSTQWHDLDSQYSGVLGHIENAAQKADQ--------NKFKFLKPNLNAAKDSWKTLRTDAVTLKEGIKELKVET 341
22 -14.0001hci_A mol:protein length:476 ALPHA-ACTININ 2  ali model follow..  9  165...........................................................................................................................................................................................................................................................................................................................................................................................TEVRALLRKHEAFESDLAAHQDRVEQIAAIAQELNELDYHDAVNVNDRCQKICDQ---DRLGTLTQKRREALERMEKLLETIDQLHLEFAKRAAPFNNWMEGAMEDLQDMFIVHSI--------EEIQSLITAHEQFKATLPEADGERQSIMAIQNEVEKVIQSYNIRISSSNPYSTVTMDELRTKWDKVKQLVPIRDQSLQEELARQHANERLRRQFAAQANAIGPWIQNKMEEIAR-TGALEDQMNQLKQYEHNIINYKNNIDKLEGDHQLIQEALVFDNK---------HTNYTMEHIRVGWELLLTTIARTINEVETQILTR 475
23 -13.8002b9c_A mol:protein length:147 striated-muscle alpha tropomyosin  ali model follow..  12  1..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MNRRIQLVEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDE----EKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEELKTVTNNLKSLEDKVEELLSKNYHLENEVARLKKLVGE............................................................ 147
24 -13.7003c9i_A mol:protein length:242 Tail needle protein gp26  ali model follow..  8  11......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ADPSLNNPVVIQATRLDASILPRNVFSKSYLLYVIAQGTDVGAIAGKANEAGQGAYDAQV----KNDEQDVELADHEARIKQLRIDVDDHESRITANTKAITALNVRVTTAEGEIASLQTNVSALDGRVTTAENNISALQADYVSKTATTSQSLASPLNVTTSYSVGGKKAATGTANKGVFDADLTFAVSDTYTQSEIQAIANALITERRRTKAMEDA. 234
25 -13.5001ei3_A mol:protein length:491 FIBRINOGEN  ali model follow..  6  22............................................................................................................................................................................................................................................................................................................................................................................................................................................................NMHESSCKYEKNWPICVDDDWGTKCPSCCRMQGII---------DDTDQNYSQRIDNIRQQLADSQNKYKTSNRVIVETINILKPGLEGAQQLDENYGHVSTELRRRIVTLKQRVATQVNRIKALQNSIQEQVVEMKRLEVDIDIKIRACKGSCARSFDYQVDKEGYDNIQKHL-TQASSIDMHPDFQTTTLSTLKMRPLKDSNVPEHFKLKPSPEMQAMSAFNNIKQMQVVLERPETDHVAEARGDSSPSHTGKL..... 267
26 -13.4003fhn_A mol:protein length:706 Protein transport protein TIP20  ali model follow..  10  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................GAMGSMNGIDDLLNINDRIKQVQNERNELASKLQNLKQSLASNDTEVALSEVIAQDIIEVGASVEGLEQLRAKYGDLQ--ILNKLEKVAVQQTQMQAGVDKLDSFERQLDELAEQPPDQFT--LDDVKALHSKLTSVFATVPQINNIDSQYAAYNKLKSKVTGKYNDVIIQ-----RLATNWSNTFDQKLLEAQWDTQKFASTSVGLVKCLRENSTKLYQLSLLYLPLEEEKSLANNFNVRFTYHFHATSSSSKIETYFQFLNDYLAENLYKCINIFHD. 294
27 -13.4003tnf_B mol:protein length:384 LidA  ali model follow..  7  17..........................................................................................................................................................................................................................................................................................................................................................................................IKKGEELEKKLDKLERQGKDLEDKYKTYEENLEGFEKLLTDSEELSLSEINEKMEAEKHKGDEKTVQSLQREHHDIKAKLANLQVLHDAHTGKKSYVNEKGNPVSSLKDAHLAINKDQEVVEHEGQFYLLQKGQWDAIKNNPAALEKAQKDYSQSKHDLATI--KMEALIHKLSLEMEKQLETINNLIMSTDPKENEEATKLLHKHNGLNLKLANLQDMLAVHRKEKSFFNEKGEEVTSLNDAHYGKDQQLFNLGGKFYPIHKEQKILEKDGKFLLKQGEDWESIKDSPEKQKKAEHDFHKLQYETPMTVKKLVHHNKGLET..... 351
28 -13.2001bf5_A mol:protein length:575 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPT  ali model follow..  7  2..................................................................................................................................................................................................................................................................................................................................................................................................................................................DKQKELDSKVRNVKDKVMCIEHEIKSLEDLQDEYDFKCKTLQNREHET-----NGVAKSDQKQEQLLLKKMYLMLDNKRKEVVHKIIELLNVTELTQNALINDELVEWKRRQQSACIGGPPNACLDQLQNWFTIVAESLQQVRQQLKKLEELEQKYTYEHDPITKNKQVLWDRTFSLFQQLIQSSFVVERQHPQRPLVLKTGVQFTVKLRLLVKLQELNYNLKVKVLFDKDVNERNTVKGFRKFNILGTHTKVMNMEESTNGSLA...... 266
29 -12.9003iox_A mol:protein length:497 AgI/II  ali model follow..  9  1.................................................................................................................................................................................................................................................................................................................................................................................................................................................AANEADYQAKLTAYQTELARVQKANADAKAAYEAAVAANNAANAALTAENTAIKKADAKADYEAKLAKYQADLAKYQKDLADYPVKLKAYEDEQTSIKAALAELEKHKNEDGN----LTEPSAQNLVYDLEPNANLSLTTDGKFLKASAVDDAFSKSTSKAKYDQKILQLDDLDITNLEQSNDVASSMELYGNFGDKAGWSTTVSNNSQVKWGSVLLERGQSATATYTNLQNSYYNGKKISK.............................. 240
30 -12.9003l4q_C mol:protein length:170 Phosphatidylinositol 3-kinase regulatory subu  ali model follow..  10  2...............................................................................................................................................................................................................................................................................................................................................................................................................................................................QQDQIVKEDSVEAVGAQLKVYHQQYQDKSREY-------------DQLYEEYTRTSQELQMKRTAIEAFNETIKIFEEQGQTQEKSSKEYLERF---------RREGNEKEMQRILLNSERLKSRIAEIHESRTKLEQELRAQASDNREIDKRMNSLKPDLMQLRKIRDQYLVWLTQKGARQKKINEWLG.................................................................... 169
31 -12.9001sj8_A mol:protein length:308 Talin 1  ali model follow..  9  1.................................................................................................................................................................................................................................................................................................................................................................................................RGHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFETLPPLGQDAASKAWRKNKMDESKHEIHSQVDAITAGTASVVNLTAGDPAETD------------------YTAVGCAVTTISSNLTEMSRGVKLLAALLEDEGGNGRPLLQAAKGLAGAVSELLRSAQPASAEPRQNLLQAAGNVGQASGELLQQIGESDTDPHFQDVLMQLANAVASAAAALVLKAKSVAQRTED-QTQVIAAATQCALSTSQLVACTKVVAPTISSPVCQEQLVEAGRLVAKAVEGCVSASQAATEDGQLLRGVGAAATAVTQALNELLQH. 303
32 -12.9002bsg_A mol:protein length:487 FIBRITIN  ali model follow..  11  45................................................................................................................................................................................................................................................................................................................................................................................................MNRPTVSVLRNVEVLDKNIGILKTSLETANSDIKTIQGIL-DVSGDIEALAQIGINKKDISDLKTLTSEHTEILNGTNNTVDSILADIGPFNAEANSVYRTIRNDWIKRELGQYTGQDINGLPVVGNPSSGMKHRIINNTDVITSQGIRLSELETKFIES------DVGSLTIEVGNLREELPKPPSFSQNVYSRLNEIDTKQTTVESDISAIKTSIGYPG------NNSIITSVNTNTDNIASINLELNQSGGIKQRLTVIETSIGSDDIPSSIKGQIKDNTTSIESLNGIVGENTS--SGLRANVSWLNQIVGT..... 348
33 -12.7002d3e_A mol:protein length:134 General control protein GCN4 and Tropomyosin  ali model follow..  15  1.......................................................................................................................................................................................................................................................................................................................................................................................................................................................MEDKVEELLSKNYHLENEVARLKKLLERAEERAELSEGKC-------------AELEEELKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAE----RSVTKLEKSIDDLEDELYAQKLKYKAISEELDHALNDMTS.................................................................................................................... 133
34 -12.7001sjj_A mol:protein length:863 actinin  ali model follow..  8  274............................................................................................................................................................................................................................................................................................................................................................................................ENRAPENTMQAMQQKLEDFRDYRRLHKPPKVQEKCQLEINFNTLQTKLRLSNRPAFMPSEGKMVSDINNAWGGLEQAEKGYEEWLLNEIRRLERLDHLAEK-------RQKASIHESWTDGKEAMLQQKDSEIKALLKKHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNARCQKICDQWDNLGALTQKRREALERTEKLLETIDQLYLEYAKRAAPFNNWMEGAMEDLQD-IEEIQGLTTAHEQFKATLPDADKERQAILGIHNETITPQEINGKWEHVRQLVPRRDQALMEEHARQQQNERLRKQFGAQANVI.... 618
35 -12.6003mtt_A mol:protein length:187 Phosphatidylinositol 3-kinase regulatory subu  ali model follow..  9  1................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MIVKEDSVEAVGAQLKVY------HQQYQDKSREYDQLYEEYTRTSQELQMKRTAIEAFNETIKIFEEQGQTQEKCSKEYLERFRREGNE--KEMQRILLNSERLKSRIAEIHESRTKLEQQLRAQASDNREIDKRMNSLKPDLMQLRKIRDQYLVWLTQKGARQKKINEWLGIKNETEDQYALMEDLE.................................................... 181
36 -12.5002xnx_M mol:protein length:146 M PROTEIN  ali model follow..  14  1..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MVWDRQRLEKELEEKKEALELAIDQASRDYHRATALEKELEEKKKALELAI----DQASQDYNRANVLEKELEAITREQEINRNLLGNAKLELDQLSSEKEQLTIEKAKLEEEKQISDASRQSLRRDLDASREAKKQVEKDLLE................................................................... 140
37 -12.5003na7_A mol:protein length:256 HP0958  ali model follow..  11  2.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GSNTHLKQLIEISHLDKEIDSLEPLIREKRKDLDKALNDKEAKNKAILNLEEEKLALKLQVSKNEQTLQDTNAKIASIQKKMERELRSLNIEEDIAKERSNQANREIENLQNEIKRKSEKQEDLKKEMLELEKLALELESLVENEVKNIKETQQIIFKKKEDLVEKTEP............................................................... 175
38 -12.5001bg1_A mol:protein length:596 PROTEIN (TRANSCRIPTION FACTOR STAT3B)  ali model follow..  7  3...............................................................................................................................................................................................................................................................................................................................................................................................................................................ANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTL---KSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGG 296
39 -12.4002ap3_A mol:protein length:199 conserved hypothetical protein  ali model follow..  11  15.....................................................................................................................................................................................................................................................................................................................................................................................................................................................KKEIKAYLKQVDKIKDDEEPIKTVGKKIAELDEKKKKLTEDV--------NSKDTAVRGKAVKDLIKNADDRLKEFEKEEDAIKKSEQDFKKAKSHVDNIDN-----------------DVKRKEVKQLDDVLKEKYKLHSDYAKAYKKAVNSEKTLFKYLNQNDATQQGVNEKSKAIEQNYKKLKEVSDKYTKVLNKVQKEKQDVDQFK.......................................................... 199
40 -12.3001quu_A mol:protein length:250 HUMAN SKELETAL MUSCLE ALPHA-ACTININ 2  ali model follow..  8  1............................................................................................................................................................................................................................................................................................................................................................................................................................................GSSNEIRRLERLEHLAEKFRQKASTHETWAYGKEQILLQKDYESASLTE--------------VRALLRKHEAFESDLAAHQDRVEQIAAIAQELNELDYHDAVNVNDRCQKICDQWDRLGTLTQKRREALERMEKLLETIDQLHLEFAKRAAPFNNWMEGAMEDLQDMFIVHSIEEI--QSLITAHEQFKATLPEADGERQSIMAIQNEVEKVIQSYNIRISSSN--PYSTVTMDELRTKWDKVKQLVPIRDQSLQEELARQHANER......... 250
41 -12.2003iyk_A mol:protein length:526 VP5  ali model follow..  8  63.....................................................................................................................................................................................................................................................................................................................................................................................................................................ESYGESVKQAVLLNVLGSGEEIPDPLSPGERGIQAKLKELEDEQRNELVRLKYNDKIKEKF------GKELEEVYNFMNGEANAEIEDEKQFDILNKAVTSYNKILTEEDLQMRRLATALQKEIGERTHAETVMVKEYRDKIDALNAIEVERDGMQEEAIQEIAGMTADVLEAASEEVPLIGAGMATARAIEGAYKLKKVINALSGIDLTHLRTPKIEPSVVSTILEYRAKEIPDNALAVSVLSKNRAIQENHKELMHIKN---EILPRFKKAMDEEKEICGIE 342
42 -12.2002oto_A mol:protein length:155 M protein  ali model follow..  12  9............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................REVIEDLAANNPAIQNIRLRHENKDLKARLENAMEVAGRDFKRAEELEKAKQALEDQRKDLETKLKELQQDYDLAKESTSWDRQRLEKELEEKKEALELAIDQASRDYHRA---------------------TALEKELEEKKKALELAIDQASQDYNRANVLEKELE............................................................. 155
43 -12.0002wcd_A mol:protein length:309 HEMOLYSIN E, CHROMOSOMAL  ali model follow..  12  14.............................................................................................................................................................................................................................................................................................................................................................................................................................KNAIETADGALDLYNKYLDQVIPWQTFDETIKELSRFKQEYS---QAASVLVGDIKTLLMDSQDKYFEATQ--TVYEWCGVATQLLAAYILLFDEYNEASAQKDILIKVLDDGITKLNEAQKSLL----VSSQSFNNASGKLLALDSQLTNDFSEKSSYFQSQVDKIRKEAYAGAAAGVVAGPFGLIISYSIAAGVVEGKLIPELKNKLKSVQNFFTTLSNTVKQANKDIDAAKL------KLTTEIAAIGEIKTETETTRFYVDYDDLMLSLLKEAAKKMINTCNEYQK.. 290
44 -12.0001u4q_A mol:protein length:322 Spectrin alpha chain, brain  ali model follow..  8  3...........................................................................................................................................................................................................................................................................................................................................................................................NKQQNFNTGIKDFDFWLSEVEALLASEDYGKDLASVN--NLLKKHQLLEADISAHE--DRLKDLNSQADSLMTSSAFDTSQVKDKRETINGRFQRIKSMAAARRAKLNESHRLHQFFRDMDDEESWIKEKKLLVSSEDTGVQNLRKKHKRLEAELAAHEPAIQGVLDTGKKLSDDNTIGKEEIQQRLAQFVDHWKELKQLAAARGQRL---------------EESLEYQQFVANVEEEEAWINEKMTASEDYGDTLAAIQGLLKKHEAFETDFTVHKDRVNDVCANGEDLENITAKMKGLKGKVSDLEKAAAQRKAKLDE..... 319
45 -11.9002ocy_A mol:protein length:154 Rab guanine nucleotide exchange factor SEC2  ali model follow..  11  2...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MALSTQLIESVDKQSHLEEQLNKSLKTIASQKAAIENYNQLKEDYN-TLKRELSDRDDEVKRLREDIAKENELRTKAEEEADKLNKEVEDLTASLFDENNMVADARKEKYAIEILNKRLTEQLREKDTLLDTLTLQLKNLKKVMHSLDNEST...................................................... 153
46 -11.9003kbt_A mol:protein length:326 Spectrin beta chain, erythrocyte  ali model follow..  10  1..................................................................................................................................................................................................................................................................................................................................................................................................SNANEAQQYYLDADEAEAWIG--EQELYVISDEIPKDEEGAIVMLKRHLRQQRIKQLASRAQGLLSAGHPEGEQIIRLQGQVDKHYAGLKDVAEERKRKLENMYHLFQLKRETDDLEQWISEKEQDFDHVTLLRDKFRDFARETGAIGQERVDNVNAFIERLIDAGHSEAATIAEWKDGLNEMWADLLELIDTRMQLLAASYDLHRYFYTGAEILGLIDEKHRELPEDVGLDASTAESFHRVHTAFERDVHLLGVQVQQFQDVATRLQTAYA---------EKAEAIQNKEQEVSAAWQALLDACAGRRTQLVD..... 321
47 -11.8002a1d_D mol:protein length:329 Staphylocoagulase  ali model follow..  7  24............................................................................................................................................................................................................................................................................................................................................................................................SDWYLKGRLTSLESQFINALDILETYHYGEKEYKDAKDKLMTRILGEDQYLL------------ERKKVQYEEYKKLYQKYKEENPTSKLKLKTFDQYTIEDLTMREYNELTESLKSAVKDFEKDVEKIENQHHDLKPFTDEMEEKATSRVDDLANKAYSVYFAFVRDTQHKTEALELKAKV--DLVLGDEDKPHRISNERIEKEMIKDLESIIEDFFIETGLNK---PGNITSYDSSKHHYKNHSEGFEALVKETREAVANADEWKTKTVKKYGESETKSPVVKEENKVEDPQSPKFDNQQEVKTTAGKAEETTQPVAQ..... 327
48 -11.6002p01_A mol:protein length:323 Alpha-2-macroglobulin receptor-associated pro  ali model follow..  9  60.........................................................................................................................................................................................................................................................................................................................................................................................KKLKLDGLDEDGEKEARLIRNLNVILAKYGLDGKKDARQVTSNSLSGTQEDGL-------PRLEKLWHKAKTSGKFSGEELDKLWREFLHHKEKVHEYNVLLETL---SRTEEIHENVISPSDLSDIKGSVLHSRHTELKEKLRSINQGLDRLRRVSHQGYSTEAEFEEPRVIDLWDLAQSANLTDKELEAFREELKHFEAKIEKHNHYQKQLEIAHEKRHAESVGDGERVSRSREKHALLEGRTKELGYTVKKHLQDLSGRISRARHNE.......................................................... 322
49 -11.5003caz_A mol:protein length:294 BAR protein  ali model follow..  9  1....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AIAERLSPVFATSKSSNMEVEHWMTSLKEVEKVLDSVEPKLTS-----GTKWRVVAQHIKDICSDLNQIFNKEDPRYEVVQAGASAAHDFDVRYLDIHKHGREIARLLEKIQKYRQEI-EEIKKEYKETDKYRERYDHYKVKLDNLEKKNKDQERIERNQQKFKDAEAAYSSVCADLIQKMETVWK--KHVSIFAEAASAVWSTQ 198
50 -11.5003o1h_A mol:protein length:277 Sensor protein TorS  ali model follow..  13  2......................................................................................................................................................................................................................................................................................................................................................................................................................SGSAMIEARQVSELSTRIISSVQMLSNAQNEQERKEAGRVLFEQLESLLTHIKELGGE---------------------SFDSKLLDALESNVQNVINNLAELGVTVERKLWLAKEIDTRVEEMRLLSEELEQLTRTQVQNTSTIAVANVTHIYDLLEALDALVEVDLDLTERLHELHLLAFKMLNQIEEARTLTNVDRI---------QQIQTAFENNLKIMKRRVLAVEDPTRS-KQMSQLLTELGKRQVVFTILLQQYENNEQSQQLMQKTLELFSELNSTVNKLVDDSNKTTTK. 277
51 -11.3001tr2_A mol:protein length:1066 VINCULIN ISOFORM 1  ali model follow..  11  3.................................................................................................................................................................................................................VFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIP------------------------------DLTAPVAAVQAAVSNLVRVGKETVQTTEDQILKRDMPPAFIKVENACTKL-------------VQAAQMLQSDPYSVPARDYLIDGSRGILS-GTSDLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGKMAKMIDERQQELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNSKNQGIEEALKN---------RNFTVEKMSAEINEIIRVLQTSWDEDAWASKDTEAMKRALASIDSKLNQAKGWLRDPSASPGDAGEQAIRQILDEAGKVGELGKERREILGTCKMLGQMTDQVADLRARGQGSSPVAMQKAQQVSQGLDVLTAKVENAARKLEAMTNSKQSIAKKIDAAQNWLADPNGGPEGEEQIRGALAEARKIAELCDKERDDILRSLGEISALTSKLADLRRQ. 451
52 -11.3002fxm_A mol:protein length:129 Myosin heavy chain, cardiac muscle beta isofo  ali model follow..  16  7..........................................................................................................................................................................................................................................................................................................................................................................................................................................................KSAEREKEMASMKEEFTRLKEALEKSEARRKELEEKM-------------VSLLQEKNDLQLQVQAEQDNLADAEERCDQLIKNKIQLEAKVKEMNERLEDEE----EMNAELTAKKRKLEDECSELKRDIDDLELTLAK........................................................................................................................... 129
53 -11.2003edv_A mol:protein length:323 Spectrin beta chain, brain 1  ali model follow..  9  1.............................................................................................................................................................................................................................................................................................................................................................................................................................................GSHMRHRLFQLNREVDDLEQWIAEREVVAEHVTMLQERFREFARDTGNIGQERVDTVNHDELINSGHSDAATIAEWKDGLNEAWADLLELIDTRTQILAKFYHDAKEIFGRIQDKHKKLPEELGRDQNTVETLQRMHTTFEHDIQALGTQVRQLQED--AARLQAAYAGDKADDIQKRENEVLEAWKSLLDACESRRVRLVDTGDDVSSVELLMNNHQGIKAEIDARNDSFTTCIELGKSLEEIKEKLLQLTEKRKEMIDKWEDRWEWLR...... 322
54 -11.2002iak_A mol:protein length:224 Bullous pemphigoid antigen 1, isoform 5  ali model follow..  7  3........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MQIRKPLLKSSLLDQNLTEEEVNMKFVQDLLNWVDEMQVQ-ESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLSYTDKLHRLESQYAKLLNTSRNQERHLDTLHNFVTRATNELIWLNEKEESEVAYDWSER---------NSSVARKKSYHAELMRELEQKEESIKAVQEIAEQL---------LLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQHIQE..... 224
55 -11.1003i9w_A mol:protein length:290 Sensor protein torS  ali model follow..  6  2.........................................................................................................................................................................................................................................................................................................................................................................................................SHMSQVEKDNTQALIPTMNMARQLSEASAWELFAAQNLTSADNEKMWQAQGRMLTAQSLKINALLQALRE------------------------QGFDTTAIEQQEQEISRSLRQQGELVGQRLQLRQQQQQLSQQIVAAADEIARLAQGQANNATTSAGATQAGIYDLIEQLDRLIDIDLEYVNQMNELRLSALRVQQMVMNLGLEQI---------QKNAPTLEKQLNNAVKILQRRQIRIEDPGVR-AQVATTLTTVSQYSDLLALYQQDSEISNHLQTLAQNNIAQFAQFSSEVSQLVDTIELRNQH. 287
56 -11.1001mql_B mol:protein length:221 Hemagglutinin HA2 chain  ali model follow..  8  11.................................................................................................................................................................................................................................................................................................................................................................................................................................................ENGWEGMIDGWYGFRHQNSEGTGQAADLKSTQAAIDQINRKLNRVIEK------TNEKFHQIEKEFSEVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLADSEMNKLFEKTRRQLRENAEDMGNGCFKIYHKDNACIESIRNGTYDHDIYRDEALNNRFQIKGVELKSGYKDW............................................................................................ 185
57 -10.9002e7s_A mol:protein length:135 Rab guanine nucleotide exchange factor SEC2  ali model follow..  14  2..........................................................................................................................................................................................................................................................................................................................................................................................................................................................PLGSLEEQLNKSLKTIASQKAAIENYNQLKEDYNTL----------KRELSDRDDEVKRLREDIAKENELRTKAEEEADKLNKEVEDLT---ASLFDEANNLVADARMEKYAIEILNKRLTEQLREKDMLLDTLTLQLKNLKKVMHS.................................................................................................................... 135
58 -10.8001st6_A mol:protein length:1069 Vinculin  ali model follow..  11  6.................................................................................................................................................................................................................VFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIP------------------------------DLTAPVSAVQAAVSNLVRVGKETVQTTEDQILKRDMPPAFIKVENACTKL-------------VRAAQMLQADPYSVPARDYLIDGSRGILS-GTSDLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGKMAKMIDERQQELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNTKSQGIEEALKN---------RNFTVEKMSAEINEIIRVLQTSWDEDAWASKDTEAMKRALALIDSKMNQAKGWLRDPNAPPGDAGEQAIRQILDEAGKAGELCAGRREILGTCKTLGQMTDQLADLRARGQGATPMAMQKAQQVSQGLDLLTAKVENAARKLEAMTNSKQAIAKKIDAAQNWLADPNGGSEGEEHIRGIMSEARKVAELCEKERDDILRSLGEISALTAKLSDLRRH. 454
59 -10.7003pdy_A mol:protein length:210 Plectin  ali model follow..  7  2......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SHMELEDSTLRYLQDLLAWVEENQPSVEAQLGSHRGLHQSIEEFRAKIERARSDEGQLSPATRGAYRDCLGRLDLQYAKLLNSSKARLRSLESLHSFVAAATKELMWLNEKEEEEVGFDWSDR---------NTNMTAKKESYSALMRELELKEKKIKELQNAGDRL---------LREDHPARPTVESFQAALQTQWSWMLQLCCCIEAHLKE..... 209
60 -10.7002efk_A mol:protein length:301 Cdc42-interacting protein 4  ali model follow..  9  6.................................................................................................................................................................................................................................................................................................................................................................................................................................................SGQFEVLERHTQWGLDLLDRYVKFVKERTEVEQAYAKQLRSLVKKYLPKRPAKDDPESKFSQQQSFVQILQEVNDFAGQRELVAENLVRVCLELTKYSQEMKQERKMHFQEGRRAQQQLENGFKQLENSKRKFERDCREAEKAAQTAERLDQDINATKADVEKAKQQAHLRSHMAEESKNEYAAQLQRFNR--DQAHFYFSQMPQIFDKLQDMD---------ERRATRLGAGYGLLSEAELEVPIIAKCLEGMKVAANAVKNDSHVLIELH 270
61 -10.6002pms_C mol:protein length:125 PNEUMOCOCCAL SURFACE PROTEIN A (PSPA)  ali model follow..  10  2.....................................................................................................................................................................................................................................................................................................................................................................................................................................................SHMDAEEVAPQAKIAELENQVHRLEQELKEIDESESEDYAKEGFRAPLQSKLDAKKAKLSKLEELSDKIDELDAEIAKLEDQLKAAEENNNVEDYFKEGLEKTIAAKK-----------AELEKTEADLKKAVNE..................................................................................................................................... 125
62 -10.6003i2w_A mol:protein length:290 Syndapin  ali model follow..  8  8.....................................................................................................................................................................................................................................................................................................................................................................................................................................................GNYKRTTKRIEDGYKLCNDLQQLIQERADIEKGYAKSLRTWSKKWGELIEKGPEYGTTEAAWKGVLTESERISDVHMKIKDNLNDVNSQIKTWQKENYHHTLMQIKERKDLEDLFKKAQKPWAKLLAKVEKAKADYHSACKTERSATNQERNANADSSLSPDQVKKMHDRVQKTKDQVQKCREKYEQAIAEITKYNSVYIEDMTSVFEKCQTFE-----KTRLQFFKEILFNVHSCLDLVQSLPQIYEEFSHTINNAQKDLKWWSNNH 275
63 -10.6003cl3_D mol:protein length:130 NF-kappa-B essential modulator  ali model follow..  10  2.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................HMASGSLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAE........................................................................................ 129
64 -10.5002wvr_A mol:protein length:209 GEMININ  ali model follow..  8  4.............................................................................................................................................................................................................................................................................................................................................................................................................................................................SMKQKQEEIKENIKNSSVPRRTLKMIQPSASGSLVGRENELSAGLSKRKHRNDHLTSTTSSPGVIVPESSENKNLGGVTQESFDLMIKENPSSQYWKEVAEKRRKALYEALKENEKLHKEIEQKDNEIARLKKENKELAEVAEHVQYMAELIERLNGEPLDNFESLDNQEFDSEEETVEDSLVEDSEIGTCAEGTVS............................................................... 200
65 -10.4003q8t_A mol:protein length:96 Beclin-1  ali model follow..  14  4............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SDSEQLQRELKELALEEERLIQELEDVEKNRKVVAENLEKVQAEAERLDQEEAQYQREYSEFKRQQLELDDELKSVENQMRYAQMQLDKLKK......................................................... 95
66 -10.4003mq7_A mol:protein length:121 Bone marrow stromal antigen 2  ali model follow..  3  1......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AGFSMDKANSEAARDGLRAVMEARNVTHLLQQELTEAQKGFQDVEAQAATANHTVMALMASLDAEKAQGQKKVEELEGEITTLNHKLQDASAEVERLRRENQVLSVRIADKKYYPSS...................................................................................................... 117
67 -10.3002qih_A mol:protein length:157 protein UspA1  ali model follow..  6  1..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MRGSGSATSANTDRIATAELGIAENKKDAQIAKAQANENKDGIAKNQADIQLHDKKITNLHSMVARAVGNNTQGVATNKADIAKNQADIANNIKNIYELAQQQDQHSSDIKTLAKVSAANTDRIAKNKAEADASFETLTKNQKLCSQA........................................................... 151
68 -10.3002l7b_A mol:protein length:307 Apolipoprotein E  ali model follow..  8  1.........................................................................................................................................................................................................................................................................................................................................................................................KVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRAMDETMKELKAYKSELEEQLTPVAEETRARLSK---------------ELQAAQARLGADMEDVCGRLVQYRG---EVQAMLGQSTEELRRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQ-----ERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEE-----QAQQIRLQAEAAQARLKSRFEPLEDMQRQWAGQVE---KVQAAEGTSAAPVPS..... 296
69 -10.2003nwh_A mol:protein length:112 Bone marrow stromal antigen 2  ali model follow..  2  3........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DPFTKANSEACRDGLRAVMECRNVTHLLQQELTEAQKGFQDVEAQAATCNHTVMALMASLDAEKAQGQKKVEELEGEITTLNHKLQDASAEVERLRRENQVLSVRIADKK........................................................................................................... 112
70 -10.2003edu_A mol:protein length:218 Spectrin beta chain, erythrocyte  ali model follow..  8  4............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................FQLKRETDDLEQWISEKEQDFDHVTLLRDKFRDFARETGAIGQERVDNVNAFIERLIDAGHSEAATIAEWKDGLNEMWADLLELIDTRMQLLAASYDLHRYFYTGAEILGLIDEKHRELPEDVGLDASTAESFHRVHTAFERELHLLGVQVQQFQDVATRLQTAYAGEKA--------EAIQNKEQEVSAAWQALLDACAGRRTQLVD..... 212
71 -10.2003haj_A mol:protein length:486 human PACSIN2 F-BAR  ali model follow..  11  22.....................................................................................................................................................................................................................................................................................................................................................................................................................................................GNYKRTVKRIDDGHRLCSDLMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGTVEKAWMAFMSEAERVSELHLEVKASLMN-----DDFEKIKNWQKEAFHKQMMGGFKETKEAEDGFRKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNPEQLKKLQDKIEKCKQDVLKTKEKYEKSLKELDQGTPQYENMEQVFEQCQQFEE--KRLRFFREVLLEVQKHLDLSNV--AGYKAIYHDLEQSIRAADAVE 281
72 -10.1003r6n_A mol:protein length:450 Desmoplakin  ali model follow..  7  1.................................................................................................................................................................................................................................................................................................................................................................................................................................................SGWDEFTKHVTSECLGWMRQQRAEMDMVAASVEQHINSHRGIHNSIGDYRWQLDKIKADLREKSAIYQLEEEYENLLKASFERMDHLRQLQNIIQATSREIMWIND---CEEEELLYDWSDKNTNIAQKQEAFSIRMSQLEVKEKELNKLKQESD---QLVLNQHPASDKIEAYMDTLQTQWSWILQITKKENAAYFQFFEEAQSTEAYLKGLQDSIRKKYDKNMPLQHLLEQIKELEKEREKILEYKRQVQNLVNKSKKIVQ......... 270
73 -10.1002odu_A mol:protein length:235 Plectin 1  ali model follow..  6  1...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GSHMRANELQLRWQEYRELVLLLLQWMRHHTAAFEE--RRFPSSFEEIEILWSQFLKFKEMELPAKEADKNRSKGIYQSLEGAVQAGQPPGYHPLDVEKEWGKLHVAILEREKQLRSEFERLECLQRIVTKLQMEAGLCEEQLNQADALLQS--VRLLAAGKVPQRAGEVERDLDKADSMIRLLFNDVQTLEQMYRRVYRLHKRLVAIRTEYNLRLKAGVAAPATQ 234
74 -10.1003f57_A mol:protein length:225 Spectrin beta chain, erythrocyte  ali model follow..  8  2............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NALENMYHLFQLKRETDDLEQWISEKELVASSPEQDFDHVTLLRDKFRDFARETGAIGQERVDNVNAFIERLIDAGHSEAATIAEWKDGLNEMWADLLELIDTRMQLLAASYDLHRYFYTGAEILGLIDEKHRELPEDVGLDASTAESFHRVHTAFERDVHLLGVQVQQFQDVATRLQTAYAGEKA--------EAIQNKEQEVSAAWQALLDACAGRRTQLVD..... 219
75 -10.1002efl_A mol:protein length:305 Formin-binding protein 1  ali model follow..  8  14..................................................................................................................................................................................................................................................................................................................................................................................................................................................DQFDNLEKHTQWGIDILEKYIKFVKERTEIELSYAKQLRNLSKKYQPKKNSKEEEEYKYTSCKAFISNLNEMNDYAGQHEVISENMSQIIVDLARYVQELKQERKSNFHDGRKAQQHIETCWKQLESSKRRFERDCKEADRAQQYFEKMDADINVTKADVEKARQQAQIRHQMAEDSKADYSSILQKFNHE--QHEYYHTHIPNIFQKIQEME---------ERRIVRMGESMKTYAEVDRQVIPIIKCLDGIVKAAESIKNDSQLVIEAY 277
FFAS is supported by the NIH grant R01-GM087218-01
4 7 1 9 8   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
 Locations of visitors to this page
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Ye Y, Osterman A, Overbeek R, Godzik A. Automatic detection of subsystem/pathway variants in genome analysis. Bioinformatics. 2005 Jun 1;21 Suppl 1:i478-i486.